Pages that link to "Q33278296"

The following pages link to Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure (Q33278296):

Displaying 24 items.

• Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid (Q26799981) (← links)
• Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI (Q28268126) (← links)
• Neoplasia: the second decade (Q30484000) (← links)
• Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model (Q34092162) (← links)
• High-sensitivity in vivo imaging for tumors using a spectral up-conversion nanoparticle NaYF4: Yb3+, Er3+ in cooperation with a microtubulin inhibitor (Q34288315) (← links)
• A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment (Q34765364) (← links)
• Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts (Q35322855) (← links)
• Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI. (Q35402062) (← links)
• Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells (Q35650874) (← links)
• Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. (Q36433061) (← links)
• Tumour vascular disrupting agents: combating treatment resistance (Q37280244) (← links)
• The War on Cancer rages on. (Q37478602) (← links)
• Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies (Q37534993) (← links)
• Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model (Q37628989) (← links)
• Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism (Q37958731) (← links)
• Barriers to drug delivery in solid tumors (Q38234567) (← links)
• Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? (Q38933699) (← links)
• Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts (Q38976012) (← links)
• Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates (Q39657204) (← links)
• A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. (Q45966683) (← links)
• Neoplasia: An Anniversary of Progress (Q46932476) (← links)
• Investigating Low-Velocity Fluid Flow in Tumors with Convection-MRI. (Q50113403) (← links)
• Interstitial fluid pressure: A novel biomarker to monitor photo-induced drug uptake in tumor and normal tissues. (Q50863174) (← links)
• Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells. (Q53085465) (← links)